Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 10,940 other HR bills in the 119th — cohort avg 30d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2026 · third_quarter · Financial Institutions/Investments/Securities
Cannabis banking for financial institutions including on the issue of debanking and the SAFE Banking Act (HR 9471) The CLIMB Act (HR 7987) related to access to capital for cannabis businesses.
Client expense: Not reported · Firm income: Not reported
Referred to the House Committee on Financial Services.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Banking
USCR is advancing a legislative agenda that allows for (1) the rescheduling of cannabis from Schedule I to Schedule III on the Controlled Substances Act (2) states to set their own policies related to cannabis (2) allows for the safe banking (HR 9471) and access to capital for the state-regulated cannabis industry (The CLIMB Act HR 7987) (3) Advances aspect of cannabis research (4) ends needless arrests and incarceration for cannabis conduct. Specific bills include opposing HR 1447 the No Deductions for Marijuana Businesses Act, supporting the SAFE Banking Act (HR 9471)), and supporting the Veterans Equal Access Act. USCR supports other legislative initiatives that move towards ending federal cannabis prohibition including the States Act 2.0 and the Evidence Based Drug Policy Act
Client expense: Not reported · Firm income: $45,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Banking
H.R.9471 - SAFE Banking Act of 2026; H.R.7987 - Capital Lending and Investment for Marijuana Businesses Act (CLIMB Act).
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Banking
Discussed the need for legal cannabis businesses to have access to financial resources and policies to protect financial institutions and other business assistance providers who service state-regulated cannabis businesses, including support for the SAFE Banking Act (S.4942/H.R.9471) before and after its reintroduction in the 119th Congress and the CLIMB Act (H.R.7987). Also discussed the need for updated FinCEN guidance from Treasury with rescheduling.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Taxation/Internal Revenue Code
Discussed incremental and comprehensive federal cannabis reforms, including the ongoing rescheduling of marijuana, recognizing state cannabis policies and programs, allowing financial institutions and other business assistance providers to service regulated cannabis businesses; Supporting the SAFE Banking Act (S.4942/H.R.9471), the CLIMB Act (H.R.7987), and the STATES 2.0 Act (H.R.2934); Opposing the No Deductions for Marijuana Businesses Act (S.471/S.471).
Client expense: Not reported · Firm income: Not reported
2026 · first_quarter · Banking
Discussed incremental and comprehensive federal cannabis reforms, including the ongoing rescheduling of marijuana, recognizing state cannabis policies and programs, allowing financial institutions and other business assistance providers to service regulated cannabis businesses; Supporting the SAFE Banking Act (S.4942/H.R.9471), the CLIMB Act (H.R.7987), and the STATES 2.0 Act (H.R.2934); Opposing the No Deductions for Marijuana Businesses Act (S.471/S.471).
Client expense: Not reported · Firm income: Not reported
2026 · first_quarter · Budget/Appropriations
Discussed incremental and comprehensive federal cannabis reforms, including the ongoing rescheduling of marijuana, recognizing state cannabis policies and programs, allowing financial institutions and other business assistance providers to service regulated cannabis businesses; Supporting the SAFE Banking Act (S.4942/H.R.9471), the CLIMB Act (H.R.7987), and the STATES 2.0 Act (H.R.2934); Opposing the No Deductions for Marijuana Businesses Act (S.471/S.471).
Client expense: Not reported · Firm income: Not reported
2026 · first_quarter · Law Enforcement/Crime/Criminal Justice
Discussed incremental and comprehensive federal cannabis reforms, including the ongoing rescheduling of marijuana, recognizing state cannabis policies and programs, allowing financial institutions and other business assistance providers to service regulated cannabis businesses; Supporting the SAFE Banking Act (S.4942/H.R.9471), the CLIMB Act (H.R.7987), and the STATES 2.0 Act (H.R.2934); Opposing the No Deductions for Marijuana Businesses Act (S.471/S.471).
Client expense: Not reported · Firm income: Not reported
2026 · second_quarter · Banking
H.R.9471 - SAFE Banking Act of 2026; H.R.7987 - Capital Lending and Investment for Marijuana Businesses Act (CLIMB Act).
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Financial Institutions/Investments/Securities
Cannabis banking for financial institutions including on the issue of debanking and the SAFE Banking Act (HR 9471) The CLIMB Act (HR 7987) related to access to capital for cannabis businesses.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Banking
USCR is advancing a legislative agenda that allows for (1) the rescheduling of cannabis from Schedule I to Schedule III on the Controlled Substances Act (2) states to set their own policies related to cannabis (2) allows for the safe banking (HR 9471) and access to capital for the state-regulated cannabis industry (The CLIMB Act HR 7987) (3) Advances aspect of cannabis research (4) ends needless arrests and incarceration for cannabis conduct. Specific bills include opposing HR 1447 the No Deductions for Marijuana Businesses Act, supporting the SAFE Banking Act (HR 9471)), and supporting the Veterans Equal Access Act. USCR supports other legislative initiatives that move towards ending federal cannabis prohibition including the States Act 2.0 and the Evidence Based Drug Policy Act
Client expense: Not reported · Firm income: $45,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Banking
USCR is advancing a legislative agenda that allows for (1) the rescheduling of cannabis from Schedule I to Schedule III on the Controlled Substances Act (2) states to set their own policies related to cannabis (2) allows for the safe banking and access to capital for the state-regulated cannabis industry (The CLIMB Act HR 7987) (3) Advances aspect of cannabis research (4) ends needless arrests and incarceration for cannabis conduct. Specific bills today include opposing HR 1447 the No Deductions for Marijuana Businesses Act, supporting the SAFE Banking Ac t(to be introduced in 119th Congress), and supporting the Veterans Equal Access Act. USCR supports other legislative initiatives that move towards ending federal cannabis prohibition including the States Act 2.0 and the Evidence Based Drug Policy Act
Client expense: Not reported · Firm income: $45,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Financial Institutions/Investments/Securities
Cannabis banking for financial institutions including on the issue of debanking and the SAFE Banking Act. The CLIMB Act (HR 7987) related to access to capital for cannabis businesses.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Banking
S.2860 - The Secure and Fair Enforcement Regulation Banking Act (SAFER Banking Act); H.R. 7987 - Capital Lending and Investment for Marijuana Businesses Act (CLIMB Act).
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| NY |
| Troy A. Carter | Democratic | LA |